Target intelligence / Profile preview

Voltage- and ligand-gated ion channels and transporters

Molecular classification
Ion channel, Transporter, Receptor
01

Overview

Voltage- and ligand-gated ion channels and transporters represent a vast and heterogeneous group of membrane proteins that regulate the flux of ions and molecules across cellular membranes. Voltage-gated channels are essential for generating and propagating action potentials in excitable tissues, while ligand-gated channels mediate rapid synaptic transmission in response to neurotransmitters (Alexander SP, et al., 2023). Transporters, including solute carriers and ATP-powered pumps, maintain cellular homeostasis by moving nutrients, ions, and waste products against or along concentration gradients (Purves D, et al., 2001). These proteins are foundational to human physiology, governing processes such as cardiac rhythm, sensory perception, and renal function. Consequently, they are among the most successful classes of therapeutic targets, with drugs acting as blockers, activators, or modulators to treat a wide spectrum of disorders including epilepsy, hypertension, and clinical depression (Yu FH, Catterall WA, 2004). Their ubiquitous expression, however, necessitates high selectivity to avoid systemic toxicities such as cardiotoxicity or neurotoxicity.

Other names
Ion channels and solute carriersMembrane transport proteinsElectrogenic pores and pumpsVoltage-gated ion channels (VGICs)Ligand-gated ion channels (LGICs)Solute carrier (SLC) transportersATP-binding cassette (ABC) transporters
02

Mechanism of action

Inhibition, activation, or allosteric modulation of ion flow or solute translocation across biological membranes.

03

Biological functions

Signal transductionIon homeostasisNeurotransmissionMuscle contractionMetabolic regulationMembrane potential maintenance
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseEpilepsyNeuropathic painMetabolic disorderCystic fibrosisHypertension
05

Safety considerations

Cardiotoxicity (e.g., hERG-mediated QT prolongation)Neurotoxicity (e.g., seizures or CNS depression)Systemic electrolyte imbalancesDrug-drug interactions via transporter inhibitionOff-target effects due to high homology between family members
06

Interacting drugs

Lidocaine

8 more in the full profile.

07

Biomarkers

Electrocardiogram (ECG) intervals (e.g., QT interval)Electroencephalogram (EEG) activitySerum electrolyte concentrations (Na+, K+, Ca2+, Cl-)Plasma drug levelsRenal clearance rates

Beyond the preview

Go deeper on Voltage- and ligand-gated ion channels and transporters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage- and ligand-gated ion channels and transporters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call